Clinical Trials Sponsored by Mohd Khairul Zul Hasymi Firdaus
Total 1 results
-
Mohd Khairul Zul Hasymi FirdausPrince of Songkla UniversityCompletedDiabetes Mellitus, Type 2Malaysia
Sponsors and Collaborators
- Fondren Orthopedic Group L.L.P.
- ProteoSys AG
- Victor Montori
- Cardresearch
- Alberta Children's Hospital, Calgary, Canada
- Societa Italiana di Endoscopia Digestiva
- Norsk Proteinintolerance, Norway
- University Centre for Chronic Diseases Dekkerswald, Groesbeek, NL
- University Medical Center Goettingen
- Elim Pediatric Pharmaceuticals Inc.
- Donders Institute for Brain, Cognition and Behavior
- AMTC & Associates
- Celtaxsys Aus Pty Limited
- Rui-hua Xu, MD, PhD
- Caritas Freetown
- CRMBM-CEMEREM
- Ilustre Colegio Profesional de Fisioterapeutas de la Comunidad de Madrid
- San MediTech(Huzhou)Co.,Ltd.
- Diego Hernan Giunta, MD
- The Fifth Affiliated Hospital of Zunyi Medical College
- View Full List
Medical Conditions
- Atrial Fibrillation, Postoperative
- Plasmodium Falciparum Malaria (Drug Resistant)
- Fever, Sweats, and Hot Flashes
- Malignant Ascites Due to Epithelial Carcinoma
- Gynecologic Cancer
- Postcomatose Unawareness State
- Lymphedema of Arm
- Prostate Cancer Recurrent
- Tube Disorders Eustachian
- Normal Diameter of Optic Nerve
- Auditory Hallucination, Verbal
- Non-compressible Torso Hemorrhage
- Analgesics, Antipyretics, and Antirheumatics Causing Adverse Effects in Therapeutic Use
- Non-dystrophic Myotonias
- Orbital Tumor
- Tularaemia
- Stereotactic Radioablation for Ventricular Tachycardia
- Disturbance of Activity and Attention
- Fibromyalgia Syndrome, Primary
- Spermatogenesis Arrest
- View Full List
Drug Interventions
- PF-00868554
- Insulin
- Cetrorelix 78 mg + 78 mg
- Oxycodone, fentanyl
- Indoximod
- Flibanserin 100 mg dose every evening
- Enzalutamide, Abiraterone
- Mupirocin Calcium
- Topotecan
- Atezolizumab
- Lamivudine
- SERETIDE Diskus
- HB-202 / HB-201 alternating intravenous administration + standard of care regimen including pembrolizumab.
- CTx-1301-Dexmethylphenidate 18.75mg (randomized fixed dose)
- Ruxolitinib
- Bortezomib/dexamethasone
- Polyethylene glycol 3350
- Epimedium Prenylflavonoids Extract
- Cytarabine ARA-C
- Methotrexate
- View Full List
CROs by country
- Contract Research Organizations in Armenia
- Contract Research Organizations in Bosnia & Herzegovina
- Contract Research Organizations in Greece
- Contract Research Organizations in Guatemala
- Contract Research Organizations in Iran
- Contract Research Organizations in Ireland
- Contract Research Organizations in Jamaica
- Contract Research Organizations in Philippines
- Contract Research Organizations in Romania
- Contract Research Organizations in Spain
- Contract Research Organizations in Switzerland
- Contract Research Organizations in Uganda
- Contract Research Organizations in United States
- CRO list by country